Alto Neuroscience (ANRO) Earnings Date, Estimates & Call Transcripts → Collapse of the Petrodollar (From Colonial Metals) (Ad) Free ANRO Stock Alerts $11.81 +0.04 (+0.34%) (As of 04:34 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 14) -$0.76 Missed By -$0.30 Consensus EPS (May. 14) -$0.46 Get Alto Neuroscience Earnings AlertsEnter your email address below to receive the latest news and earnings results for ANRO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueANRO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ANRO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Alto Neuroscience Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241($0.82)($0.82)($0.82)Q3 20241($0.89)($0.89)($0.89)Q4 20241($1.04)($1.04)($1.04)20243($2.75)($2.75)($2.75)Q1 20251($0.82)($0.82)($0.82)Q2 20251($0.83)($0.83)($0.83)Q3 20251($0.86)($0.86)($0.86)Q4 20251($0.89)($0.89)($0.89)FY 20254($3.40)($3.40)($3.40)ANRO Earnings Date and InformationAlto Neuroscience last posted its earnings results on May 14th, 2024. The reported ($0.76) EPS for the quarter, missing analysts' consensus estimates of ($0.46) by $0.30. Alto Neuroscience has generated $0.00 earnings per share over the last year. Earnings for Alto Neuroscience are expected to decrease in the coming year, from ($2.93) to ($3.16) per share. Alto Neuroscience has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Alto Neuroscience Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024(Estimated)------- 5/14/2024Q1 2024($0.46)($0.76)($0.30)($0.76)-- Alto Neuroscience Earnings - Frequently Asked Questions When is Alto Neuroscience's earnings date? Alto Neuroscience has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on ANRO's earnings history. Did Alto Neuroscience beat their earnings estimates last quarter? In the previous quarter, Alto Neuroscience (NYSE:ANRO) missed the analysts' consensus estimate of ($0.46) by $0.30 with a reported earnings per share (EPS) of ($0.76). Learn more on analysts' earnings estimate vs. ANRO's actual earnings. How much revenue does Alto Neuroscience generate each year? Alto Neuroscience (NYSE:ANRO) has a recorded annual revenue of $210,000.00. How much profit does Alto Neuroscience generate each year? Alto Neuroscience (NYSE:ANRO) has a recorded net income of -$36.31 million. ANRO has generated $0.00 earnings per share over the last four quarters. What is Alto Neuroscience's EPS forecast for next year? Alto Neuroscience's earnings are expected to decrease from ($2.93) per share to ($3.16) per share in the next year. More Earnings Resources from MarketBeat Related Companies: MannKind Earnings Calliditas Therapeutics AB (publ) Earnings Day One Biopharmaceuticals Earnings AbCellera Biologics Earnings Mirum Pharmaceuticals Earnings Prothena Earnings Collegium Pharmaceutical Earnings Enliven Therapeutics Earnings Cassava Sciences Earnings Arcturus Therapeutics Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NYSE:ANRO) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
